These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 9580849)

  • 1. Treatment of advanced (stages III and IV) non-small-cell lung cancer.
    Sweeney CJ; Sandler AB
    Curr Probl Cancer; 1998; 22(2):85-132. PubMed ID: 9580849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic overview of chemotherapy effects in non-small cell lung cancer.
    Sörenson S; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):327-39. PubMed ID: 11441939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined modality therapy of non-small cell lung cancers.
    Juretic A; Sobat H; Samija M
    Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA
    Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel-based combined-modality chemoradiotherapy for locally advanced non-small cell lung cancer.
    Scagliotti GV; Turrisi AT
    Oncologist; 2003; 8(4):361-74. PubMed ID: 12897333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy.
    Socinski MA
    Clin Lung Cancer; 2004 Mar; 5(5):274-89. PubMed ID: 15086966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined-modality treatment of locally advanced non-small cell lung cancer: incorporation of novel chemotherapeutic agents.
    Belani CP; Ramanathan RK
    Chest; 1998 Jan; 113(1 Suppl):53S-60S. PubMed ID: 9438691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
    Tieu BH; Sanborn RE; Thomas CR
    Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical studies in non-small cell lung cancer: the CALGB experience.
    Vokes EE; Green MR
    Cancer Invest; 1998; 16(2):72-9. PubMed ID: 9512672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
    Belani CP
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer: a time for reassessment?
    Bunn PA; Mault J; Kelly K
    Chest; 2000 Apr; 117(4 Suppl 1):119S-122S. PubMed ID: 10777465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical treatment for stage III non-small-cell lung cancer (NSCLC)].
    Okamoto H; Watanabe K
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):841-8. PubMed ID: 17565244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer: a review of current therapeutic modalities.
    Sandler AB; Buzaid AC
    Lung; 1992; 170(5):249-65. PubMed ID: 1325579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined modality treatment of non-small-cell lung cancer.
    Westeel V; Depierre A
    Am J Respir Med; 2003; 2(6):477-90. PubMed ID: 14719987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent issues in the treatment of advanced non-small-cell lung cancer].
    Negoro S
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1671-9. PubMed ID: 9757191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant Therapy in Non-Small Cell Lung Cancer.
    Zheng Y; Jaklitsch MT; Bueno R
    Surg Oncol Clin N Am; 2016 Jul; 25(3):567-84. PubMed ID: 27261916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant treatment of lung cancer: current status and potential applications of new regimens.
    Le Chevalier T; Lynch T
    Lung Cancer; 2004 Dec; 46 Suppl 2():S33-9. PubMed ID: 15698530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.